Literature DB >> 23147500

The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.

Leslie Z Benet1.   

Abstract

Biopharmaceutics Classification System and Biopharmaceutics Drug Distribution Classification System are complimentary, not competing, classification systems that aim to improve, simplify, and speed drug development. Although both systems are based on classifying drugs and new molecular entities into four categories using the same solubility criteria, they differ in the criterion for permeability and have different purposes. Here, the details and applications of both systems are reviewed with particular emphasis of their role in drug development.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23147500      PMCID: PMC3684558          DOI: 10.1002/jps.23359

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  33 in total

Review 1.  Computational approaches to the prediction of the blood-brain distribution.

Authors:  Ulf Norinder; Markus Haeberlein
Journal:  Adv Drug Deliv Rev       Date:  2002-03-31       Impact factor: 15.470

Review 2.  Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

Authors:  Fabio Broccatelli; Caroline A Larregieu; Gabriele Cruciani; Tudor I Oprea; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2011-12-21       Impact factor: 15.470

3.  Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes.

Authors:  Travis T Wager; Ramalakshmi Y Chandrasekaran; Xinjun Hou; Matthew D Troutman; Patrick R Verhoest; Anabella Villalobos; Yvonne Will
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

4.  The BCS, BDDCS, and regulatory guidances.

Authors:  Mei-Ling Chen; Gordon L Amidon; Leslie Z Benet; Hans Lennernas; Lawrence X Yu
Journal:  Pharm Res       Date:  2011-04-14       Impact factor: 4.200

5.  BDDCS applied to over 900 drugs.

Authors:  Leslie Z Benet; Fabio Broccatelli; Tudor I Oprea
Journal:  AAPS J       Date:  2011-08-05       Impact factor: 4.009

6.  Dedication to professor Leslie Z. Benet: 50 years of scientific excellence and still going strong!

Authors:  David E Smith; Malcolm Rowland; Kathleen M Giacomini; Gordon L Amidon
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

7.  Effects of uremic toxins on transport and metabolism of different biopharmaceutics drug disposition classification system xenobiotics.

Authors:  Maribel Reyes; Leslie Z Benet
Journal:  J Pharm Sci       Date:  2011-05-26       Impact factor: 3.534

8.  Effect of single-dose rifampin on the pharmacokinetics of warfarin in healthy volunteers.

Authors:  A Frymoyer; S Shugarts; M Browne; A H B Wu; L Frassetto; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  2010-08-11       Impact factor: 6.875

9.  BDDCS class prediction for new molecular entities.

Authors:  Fabio Broccatelli; Gabriele Cruciani; Leslie Z Benet; Tudor I Oprea
Journal:  Mol Pharm       Date:  2012-02-07       Impact factor: 4.939

10.  pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.

Authors:  Manthena V Varma; Iain Gardner; Stefanus J Steyn; Paul Nkansah; Charles J Rotter; Carrie Whitney-Pickett; Hui Zhang; Li Di; Michael Cram; Katherine S Fenner; Ayman F El-Kattan
Journal:  Mol Pharm       Date:  2012-04-26       Impact factor: 4.939

View more
  47 in total

Review 1.  BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.

Authors:  Chelsea M Hosey; Rosa Chan; Leslie Z Benet
Journal:  AAPS J       Date:  2015-11-20       Impact factor: 4.009

Review 2.  Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.

Authors:  Karlyn A Martin; Craig R Lee; Timothy M Farrell; Stephan Moll
Journal:  Am J Med       Date:  2017-02-01       Impact factor: 4.965

Review 3.  Drug-Nutrition Interactions and the Brain: It's Not All in Your Head.

Authors:  Joseph I Boullata
Journal:  Curr Nutr Rep       Date:  2019-06

4.  Biopharmaceutical Evaluation and CMC Aspects of Oral Modified Release Formulations.

Authors:  Rong-Kun Chang; Neil Mathias; Munir A Hussain
Journal:  AAPS J       Date:  2017-07-05       Impact factor: 4.009

5.  Evaluation of DILI Predictive Hypotheses in Early Drug Development.

Authors:  Rosa Chan; Leslie Z Benet
Journal:  Chem Res Toxicol       Date:  2017-03-15       Impact factor: 3.739

Review 6.  Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop.

Authors:  Corie A Ellison; Karen L Blackburn; Paul L Carmichael; Harvey J Clewell; Mark T D Cronin; Bertrand Desprez; Sylvia E Escher; Steve S Ferguson; Sébastien Grégoire; Nicola J Hewitt; Heli M Hollnagel; Martina Klaric; Atish Patel; Sabrina Salhi; Andreas Schepky; Barbara G Schmitt; John F Wambaugh; Andrew Worth
Journal:  Regul Toxicol Pharmacol       Date:  2019-01-15       Impact factor: 3.271

7.  Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions.

Authors:  Chelsea M Hosey; Leslie Z Benet
Journal:  Mol Pharm       Date:  2015-04-23       Impact factor: 4.939

8.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

9.  Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls.

Authors:  Mark G Papich; Marilyn N Martinez
Journal:  AAPS J       Date:  2015-04-29       Impact factor: 4.009

10.  Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

Authors:  Raj Vuppalanchi; Raghavender Gotur; K Rajender Reddy; Robert J Fontana; Marwan Ghabril; Andrzej S Kosinski; Jiezhun Gu; Jose Serrano; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-20       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.